Evidence before interpretation.
ClinicOps research turns public records and supplied documents into reviewable evidence. Source quality, who holds which role and what remains uncertain stay visible rather than collapsing into a compliance verdict.
The operating method
Public registers, authority pages and controlled client records have different evidentiary roles. ClinicOps keeps those distinctions visible and uses deterministic screening only where the rule can be stated and reproduced.
Current research
EUDAMED record monitoring method
Versioned public-record snapshots for a bounded watchlist, diffed over time with aggregate reporting and explicit source limitations.
SS(C)P and the public EUDAMED record
September 2026 public-source research on what published SS(C)P material and the public record can — and cannot — reconcile.
Interactive evidence specimen
A synthetic register showing provenance, observations, deterministic states, unresolved questions and human decision ownership.
Where the method applies
Medical-device regulatory operations
EUDAMED, MDR transition, SS(C)P, AR portfolios, regulatory master data and document-control reconciliation.
Denmark market access
Danish authorities, Danish-language content and the evidence handoffs that connect to the EU framework.
Secondary specialist work
Danish pharmacovigilance, controlled medical content and adjacent life-science evidence workflows remain bounded specialist extensions; they do not replace the MedTech regulatory-data-integrity flagship.
Evidence-input boundary
A missing public record, structural mismatch or machine signal is an observation to review, not an allegation. In medical-device work the manufacturer, authorised-representative, importer and notified-body roles stay attached to the evidence; they are not flattened into generic document checking.
Primary sources
Regulatory and clinical statements are grounded in official public sources where they exist. Danish work starts with the Danish authority and connects to EU legislation, Commission and EMA systems and applicable guidance. Client-controlled evidence stays distinct from public-source evidence.